Merck & Co., Inc. Tax Cuts and Jobs Act, Decrease in Deferred Tax Liability due to Transition Tax (Deprecated 2020-01-31)
Merck & Co., Inc. (MRK) reported Tax Cuts and Jobs Act, Decrease in Deferred Tax Liability due to Transition Tax (Deprecated 2020-01-31) of $2.00 billion for the 12-month period ending 2017-12-31, per its 10-K filed 2020-02-26.
Discontinued › Notes › Income Taxes
us-gaap:TaxCutsAndJobsActOf2017DecreaseInDeferredTaxLiabilityDueToTransitionTax · last filed 2020-02-26
- Merck & Co., Inc. tax cuts and jobs act, decrease in deferred tax liability due to transition tax (deprecated 2020-01-31) for fiscal 2017 was $2.00B.
| Period end | Tax Cuts and Jobs Act, Decrease in Deferred Tax Liability due to Transition Tax (Deprecated 2020-01-31) 12 month |
|---|---|
| 2017-12-31 | $2.00B 10-K · filed 2020-02-26 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| AbbVie Inc. (ABBV) | United States | $468.180B | 70.37 |
| ABBOTT LABORATORIES (ABT) | United States | $176.045B | 28.47 |
| PFIZER INC (PFE) | United States | $162.042B | 31.94 |
| VERTEX PHARMACEUTICALS INC / MA (VRTX) | United States | $132.481B | 28.56 |
| BRISTOL MYERS SQUIBB CO (BMY) | United States | $125.637B | 12.67 |
| JOHNSON & JOHNSON (JNJ) | United States | $652.528B | 29.10 |
| REGENERON PHARMACEUTICALS, INC. (REGN) | United States | $74.751B | 21.53 |
| ALNYLAM PHARMACEUTICALS, INC. (ALNY) | United States | $33.420B | 54.94 |
| Zoetis Inc. (ZTS) | United States | $29.045B | 11.38 |
| INSMED Inc (INSM) | United States | $26.566B | -26.60 |